Newsletter | December 21, 2023

12.21.23 -- Do End-To-End C(x)DMOs Really Exist?

FEATURED EDITORIAL

Understand The Importance Of Real-Time Monitoring For Protein Aggregation

This article breaks down the advantages of real-time monitoring for protein therapeutics, including how it can accelerate timelines, produce better data, and smooth regulatory compliance.

In Search Of The Unicorn: Do End-To-End C(x)DMOs Really Exist?

Focusing solely on mammalian biologics, this expert analyzed public information and a proprietary database by looking at 80 service providers supporting projects from early discovery to commercial manufacturing.

INDUSTRY INSIGHTS

Elastomer Plungers With Barrier Film For COVID-19 Vaccines

See how you can minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with an elastomer plunger laminated with FluroTec™ barrier film.

Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?

Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill/finish process.

Next-Generation Sequencing For Adventitious Agent Detection In Cell Banks

NGS-based methods for agnostic broad range detection are suitable options to augment or replace current virus testing methodology. Explore a NGS AAT method for cell line characterization and more.

NEWS HEADLINES

VEGZELMA (bevacizumab-adcd) Receives Preferred Formulary Status With Ventegra For Commercially Insured Patients

Commencement Of Construction In Lendava: The Largest Investment In Lek's History In Line With Plans

SOLUTIONS

Capture Resins For Antibody Purification

LIFE SCIENCE LEADER MAGAZINE

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.